Learning Objectives
Upon completion of this activity, participants should be able to:
- Define current criteria for resectability of liver metastases in colorectal cancer and contrast these with older criteria
- Discuss the benefits of neoadjuvant and conversion systemic therapy in patients with colorectal cancer and liver metastases
- Identify the possible risks of perioperative chemotherapy in patients with colorectal cancer and liver metastases and steps to reduce these risks
- Define future liver remnant and describe its assessment
- Explain the use and the limitations of radiofrequency ablation in patients with colorectal cancer and liver metastases
Topics covered include:
- Introduction
- Redefining Resectability
- Short-term and Long-term Results of Resection
- Using Systemic Therapy to Increase Resectability and Improve Outcomes of Resection
- Determining the Future Liver Remnant and Assessing the Need for PVE
- Two-Stage and Repeat Hepatectomies
- Radiofrequency Ablation
- Conclusion